BRIEF published on 01/09/2025 at 17:40, 1 year 5 months ago Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
PRESS RELEASE published on 01/09/2025 at 17:35, 1 year 5 months ago Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026 Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF published on 12/23/2024 at 22:10, 1 year 5 months ago Abivax Announces Board Resignation Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 5 months ago Abivax Announces a Change to the Composition of its Board of Directors Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty
BRIEF published on 12/18/2024 at 18:05, 1 year 5 months ago ABIVAX: Share capital and voting rights as of November 30, 2024 Euronext Paris Share Capital Voting Rights Abivax Investment
BRIEF published on 11/27/2024 at 18:05, 1 year 6 months ago ABIVAX: Update of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights Abivax Financial Transparency
BRIEF published on 11/19/2024 at 22:35, 1 year 6 months ago Abivax Launches ATM Program on Nasdaq Common Shares Biotechnology Funding Nasdaq ATM Program
PRESS RELEASE published on 11/19/2024 at 22:30, 1 year 6 months ago Abivax Establishes an At-the-Market (ATM) Program on Nasdaq Abivax establishes an At-the-Market (ATM) Program on Nasdaq, allowing issuance and sale of ordinary shares to raise up to $150 million. Implementation involves Piper Sandler & Co. as sales agent Ordinary Shares Abivax Nasdaq ATM Program Piper Sandler
BRIEF published on 11/14/2024 at 22:06, 1 year 7 months ago Abivax Releases Q3 2024 Financial Results Financial Results Biotechnology Abivax Ulcerative Colitis Q3 2024
PRESS RELEASE published on 11/14/2024 at 22:01, 1 year 7 months ago Abivax presents third quarter 2024 key financial information Abivax presents key financial information for the third quarter of 2024. The company announced updates on operational goals and debt status. Details on Abivax's cash and principal debt outstanding are provided Financial Information Abivax Quarter Results Clinical-stage Biotechnology Debt Status
Published on 06/18/2026 at 00:00, 9 hours 44 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 10 hours 14 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 10 hours 54 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 11 hours 14 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 16 hours 49 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/18/2026 at 09:30, 14 minutes ago AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026
Published on 06/18/2026 at 09:10, 34 minutes ago Lenzing Group highlights scalable, bio-based nonwovens solutions at leading global industry fairs
Published on 06/18/2026 at 09:05, 38 minutes ago Norwegian Water and Energy Authority selects ICEYE to deliver nationwide satellite monitoring capability
Published on 06/18/2026 at 09:00, 44 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 06/18/2026 at 09:00, 44 minutes ago Original-Research: Flughafen Wien AG (von NuWays AG): BUY
Published on 06/18/2026 at 09:06, 38 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 1 hour 14 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 2 hours 44 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 16 hours 4 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 1 day ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
